Learn More
Medchemexpress LLC [1,1'-Biphenyl]-4-carboxamide, N-[(1S)-1-(1H-benzimidazol-2-yl)-4-[(2-chloro-1-iminoethyl)amino]butyl]- | 1802637-39-3 | 98.19% | 459.97 | 25 MG

Supplier: Medchemexpress LLC 25MGHY111347
BB-Cl-Amidine is identified as a peptidylarginine deiminase (PAD) inhibitor. It is intended for research use only and not for sale to patients.
- Acts as an inhibitor of peptidylarginine deiminase (PAD).
- Demonstrated cytotoxicity against human U2OS cells with an EC50 of 8.8 μM after 72 hours by XTT assay, and an IC50 of 8.8 μM after 72 hours by MTT assay.
- In MRL/lpr mice, treatment subtly reduces splenomegaly, shows a trend towards increased circulating levels of anti-NET antibodies, and significantly improves endothelium-dependent vasorelaxation.
- Also shows a strong trend towards downregulation of IRGs and significantly improves muzzle alopecia.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.